Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012. There are no approved treatments for MERS-CoV infection although a combination of lopinavir,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheahan, Timothy P., Sims, Amy C., Leist, Sarah R., Schäfer, Alexandra, Won, John, Brown, Ariane J., Montgomery, Stephanie A., Hogg, Alison, Babusis, Darius, Clarke, Michael O., Spahn, Jamie E., Bauer, Laura, Sellers, Scott, Porter, Danielle, Feng, Joy Y., Cihlar, Tomas, Jordan, Robert, Denison, Mark R., Baric, Ralph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954302/
https://www.ncbi.nlm.nih.gov/pubmed/31924756
http://dx.doi.org/10.1038/s41467-019-13940-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954302/
https://www.ncbi.nlm.nih.gov/pubmed/31924756
http://dx.doi.org/10.1038/s41467-019-13940-6

Ejemplares similares